Literature DB >> 9532334

Understanding the thyrotropin receptor function-structure relationship.

J Sanders1, Y Oda, S A Roberts, M Maruyama, J Furmaniak, B R Smith.   

Abstract

The thyrotropin (TSH) receptor (TSHR) is a key protein in the control of thyroid function and a major thyroid autoantigen. Recently, molecular cloning of the receptor has been carried out and we now review the impact of this work on our understanding of the physiology and pathophysiology of the TSHR. Analysis of recombinant TSHR proteins expressed in prokaryotic and eukaryotic systems has indicated that post-translational processing is important for the formation of active receptors. Studies of TSHR glycosylation have shown that a 'mature' form of the receptor containing mainly complex-type sugar residues is principally involved in TSH and TSHR autoantibody (TRAb) binding. In addition, the processing of the TSHR peptide chain into two subunits observed with native TSHR has been confirmed using recombinant TSHR. However, despite considerable efforts in many laboratories, the binding site(s) for TSH and TRAb on the TSHR have not been well characterized as yet and lessons learned from the discovery of naturally occurring amino acid mutations of the TSHR confirm the complexity of the hormone and autoantibody binding sites. Future progress in producing large amounts of pure TSHR as well as monoclonal TRAbs, followed by crystallographic analysis of TSHR-TSH complexes and TSHR-TRAb complexes, should be helpful in providing a better insight into the relationship between TSHR structure and function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9532334     DOI: 10.1016/s0950-351x(97)80693-3

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  6 in total

1.  Role of complex asparagine-linked oligosaccharides in the expression of a functional thyrotropin receptor.

Authors:  S Siffroi-Fernandez; S Costagliola; S Paumel; A Giraud; J P Banga; J L Franc
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

2.  Detection of combined genomic variants in a Jordanian family with familial non-autoimmune hyperthyroidism.

Authors:  Said I Ismail; Ismail S Mahmoud; Mahmoud Al-Ardah; Amid Abdelnour; Nidal A Younes
Journal:  J Genet       Date:  2009-08       Impact factor: 1.166

3.  In vivo effects of a human thyroid-stimulating monoclonal autoantibody (M22) and a human thyroid-blocking autoantibody (K1-70).

Authors:  Jadwiga Furmaniak; Jane Sanders; Stuart Young; Katarzyna Kabelis; Paul Sanders; Michele Evans; Jill Clark; Jane Wilmot; Bernard Rees Smith
Journal:  Auto Immun Highlights       Date:  2011-09-14

Review 4.  Blocking type TSH receptor antibodies.

Authors:  Jadwiga Furmaniak; Jane Sanders; Bernard Rees Smith
Journal:  Auto Immun Highlights       Date:  2012-03-21

5.  Antibody protection reveals extended epitopes on the human TSH receptor.

Authors:  Rauf Latif; Avelino Teixeira; Krzysztof Michalek; M Rejwan Ali; Max Schlesinger; Ramkumarie Baliram; Syed A Morshed; Terry F Davies
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

6.  The hinge region of human thyroid-stimulating hormone (TSH) receptor operates as a tunable switch between hormone binding and receptor activation.

Authors:  Ritankar Majumdar; Rajan R Dighe
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.